An international, multicenter, randomized, double-blind phase III study of maintenance belagenpumatucel-l in non-small cell lung cancer (NSCLC): Updated analysis of patients enrolled within 12weeks of completion of chemotherapy (original) (raw)
An international, multicenter, randomized, double-blind phase III study of maintenance belagenpumatucel-l in non-small cell lung cancer (NSCLC): Updated analysis of patients enrolled within 12weeks of completion of chemotherapy
J. Nemunaitis
R. Ramlau
Michel van Den Heuvel hasn't uploaded this paper.
Let Michel van Den know you want this paper to be uploaded.
Ask for this paper to be uploaded.